Does inflammation reduce T4 to T3 conversion and cause low free T3 with normal TSH and free T4?

During systemic illness, trauma, or acute physiological stress, elevated inflammatory cytokines trigger a coordinated reprogramming of thyroid hormone metabolism. This response manifests clinically as non-thyroidal illness syndrome (NTIS), or euthyroid sick syndrome.

Mechanistic pathways

• Deiodinase downregulation: Pro-inflammatory cytokines (including IL-1β, IL-6, TNF-α, and IFN-γ) activate NF-κB- and AP-1-mediated signaling pathways to suppress mRNA transcription and enzymatic activity of type 1 deiodinase (DIO1) in peripheral tissues like the liver. They also directly inhibit type 2 deiodinase (DIO2) activity.
• Cofactor depletion: Cytokine-induced activation of NADPH oxidase generates reactive oxygen species (ROS) that deplete intracellular glutathione (GSH) pools. Because DIO1 and DIO2 are selenoproteins requiring GSH/thiol cofactors, this depletion further impairs their ability to convert T4 to active T3.
• Accelerated inactivation: Simultaneously, inflammation induces type 3 deiodinase (DIO3/D3) activity. DIO3 actively inactivates thyroid hormones, converting T4 to inactive reverse T3 (rT3) and active T3 to T2, compounding the drop in active hormone levels.

Clinical implications

• NTIS presentation: This enzymatic shift directly impairs peripheral conversion of T4 to active T3. Because the thyroid gland's primary secretion remains intact, patients typically present with low free T3 alongside normal TSH and normal-to-low free T4.
• Therapeutic approach: Because this biochemical pattern represents an adaptive systemic response to illness rather than intrinsic thyroid pathology, routine thyroid hormone replacement therapy is generally not clinically indicated.

Bottom line

• Systemic inflammation suppresses active T4-to-T3 conversion by downregulating DIO1/DIO2 and depleting glutathione, while upregulating the inactivating DIO3 enzyme. This leads to low free T3 despite normal TSH and free T4, a hallmark of non-thyroidal illness syndrome that typically does not warrant hormone replacement.